
|Articles|April 1, 2002
New antibiotic seen as more effective in fighting bacteria
San Francisco-Levofloxacin (Quixin, Santen)-the new kid in the fluoroquinolone family-is less likely to encounter resistant strains of bacteria than the two older members of that antibiotic family, ofloxacin (Ocuflox, Allergan) and ciprofloxacin (Ciloxan, Alcon), according to David Hwang, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
2
iOpeners with Nicole Bajic, MD: Mary Qiu, MD, on tailored NVG pathways
3
Long-lived Greenland sharks may point to new approaches for retinal disease
4
Orbital and retinal microvascular changes in thyroid eye disease
5












































